Friday, August 1, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

FDA Approves First Vagus Nerve Stimulation Device for RA

July 31, 2025
in Health News
Share on FacebookShare on Twitter


The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have not responded to — or cannot tolerate — biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs). 

The device, developed by SetPoint Medical in Valencia, California, is the first treatment of its kind approved for RA. The company is also planning trials for multiple sclerosis and Crohn’s disease. 

Implanted into the neck, the Setpoint System is a multivitamin-sized device that stimulates the vagus nerve for 1 minute every day and “is designed to activate innate anti-inflammatory pathways in the vagus nerve to reduce inflammation and restore immunologic setpoint,” according to a press release from SetPoint Medical on July 31. 

The device’s approval was based on a randomized, double-blinded, and sham-controlled clinical study of 242 patients with RA. At 3 months, 35.2% of patients in the treatment group achieved 20% improvement in American College of Rheumatology response criteria (ACR20), compared with 24.2% in the sham group, according to trial results presented at the 2024 ACR annual meeting held in Washington, DC.

ACR response rates and disease activity metrics improved over 12 months of follow-up, John Tesser, MD, a principal investigator of the trial, said in a statement. At 1 year, “75% of patients in the study were free of biologic or targeted synthetic DMARDs,” he said.

Commercialization of the device will begin in certain US cities this year, with a larger expansion across the US planned in early 2026. SetPoint could not provide specifics on which cities are selected for this phased roll out due to confidentiality requirements. 



Source link : https://www.medscape.com/viewarticle/fda-approves-first-vagus-nerve-stimulation-device-rheumatoid-2025a1000keb?src=rss

Author :

Publish date : 2025-07-31 19:00:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

Heart Drug From Nearly-Forgotten Class May Treat Alzheimer’s

Next Post

Cutting Medicaid Funding Isn’t the Only Worrisome Change to the Program

Related Posts

Health News

Gabapentin vs Pregabalin Study Teases Out Heart Risks

August 1, 2025
Health News

cUTI Care Just Got Easier: Use This 4-Step Plan

August 1, 2025
Health News

Trump Revives Presidential Fitness Test, a Rite of Passage for Schoolkids for Years

August 1, 2025
Health News

Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

August 1, 2025
Health News

Preeclampsia Prediction Moving Closer to Reality

August 1, 2025
Health News

‘I Became so Quiet’: When Physicians Attempt Suicide

August 1, 2025
Load More

Gabapentin vs Pregabalin Study Teases Out Heart Risks

August 1, 2025

cUTI Care Just Got Easier: Use This 4-Step Plan

August 1, 2025

Trump Revives Presidential Fitness Test, a Rite of Passage for Schoolkids for Years

August 1, 2025

Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

August 1, 2025

Preeclampsia Prediction Moving Closer to Reality

August 1, 2025

‘I Became so Quiet’: When Physicians Attempt Suicide

August 1, 2025

Why is it so hard to say no?

August 1, 2025

Cameras that work like our eyes could give boost to astronomers

August 1, 2025
Load More

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version